Header cover image

New Zealand Biotech Stocks

Results

4

0 new

Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.

4 companies

AFT Pharmaceuticals

Market Cap: NZ$272.7m

Engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally.

AFT

NZ$2.60

7D

-2.6%

1Y

-13.3%

Pacific Edge

Market Cap: NZ$68.2m

A cancer diagnostics company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, and internationally.

PEB

NZ$0.084

7D

5.0%

1Y

-16.0%

BLIS Technologies

Market Cap: NZ$17.9m

Develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity.

BLT

NZ$0.014

7D

-6.7%

1Y

-12.5%

Rua Bioscience

Market Cap: NZ$6.5m

Engages in the research, development, and manufacturing of pharmaceutical products in New Zealand and internationally.

RUA

NZ$0.029

7D

3.6%

1Y

-58.6%